Being Social: The FDA Pronounces on Interactive Promotional Media

October 2014Social Media Pharmaceutical

Abstract

In the United States, consumers are increasingly turning to social media to obtain information about pharmaceutical products and devices, to research medical conditions, and obtain information about potential treatments, available support groups and other health-related information. Data from Manhattan Research (for the year 2013) indicates that social media influences the patient journey in unprecedented ways: for example, upwards of 20% of consumers surveyed were “strongly influenced” by social media when experiencing symptoms, after diagnosis, or when managing their condition. Social media has also influenced patients’ interactions with their doctors: 27% of consumers using social media reported that they asked a doctor to prescribe a generic instead of a brand as a result of health/medial information they found on-line, 12% asked a doctor to prescribe a brand, and 25% asked a doctor to prescribe any drug.

Subscribe to reador

Global anti–money laundering (AML) investigations present complex operational and regulatory challenges driven by cross-border transactions, fragmented data sources, varying legal regimes, data protection and privacy requirements, and cultural barriers to...Read more

Fabiana Lacerca-Allen

Chief Compliance Officer, Cipla, USA

Kwanza Burney

Compliance & Risk Professional | M.S.L. Candidate (Fordham Law), Fordham University School of Law, USA

“Crisis-Capable Compliance: The CCO at the Crossroads of AI, Ethics, and Leadership”

The role of the Chief Compliance Officer is undergoing a fundamental transformation in the era of artificial intelligence. No longer confined to oversight and enforcement, the CCO is emerging as...Read more

Fabiana Lacerca-Allen

Chief Compliance Officer, Cipla, USA

Being Social: The FDA Pronounces on Interactive Promotional Media

Abstract

Related Papers